Induction of a hematological and cytogenetic remission in a patient with a myelodysplastic syndrome secondary to Fanconi's anemia employing the S-HAM regimen

Annals of Hematology

Volumn 74, Issue 6, 1997, Pages 275-277

  Verbeek, W ^a,b   Haase, D ^a   Schoch, C ^a   Hiddemann, W ^a   Wormann B ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Fanconi's anemia; High dose cytosine arabinoside; Myelodysplasia

Indexed keywords

CYTARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; MITOXANTRONE;

ADULT; ARTICLE; BONE MARROW HYPOPLASIA; CANCER REGRESSION; CASE REPORT; CONTROLLED STUDY; CYTOGENETICS; FANCONI ANEMIA; FEMALE; GRANULOCYTOPENIA; HEMATOPOIESIS; HUMAN; KARYOTYPE; LEUKOCYTE COUNT; MONOSOMY; MYELODYSPLASTIC SYNDROME; PANCYTOPENIA; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; TRISOMY 13; X CHROMOSOME INACTIVATION;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHROMOSOME ABERRATIONS; CYTARABINE; FANCONI ANEMIA; FEMALE; HUMANS; KARYOTYPING; MITOXANTRONE; MYELODYSPLASTIC SYNDROMES; REMISSION INDUCTION;

EID: 0030744199     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050299     Document Type: Article

References (14)

1. Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW (1992) Methylation of Hpall and Hhal sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet 51:1229-1239
2. Auerbach AD, Alien RG (1991) Leukemia and preleukemia in Fanconi anemia patients. Cancer Genet Cytogenet 51:1-5
3. Auerbach AD, Rogatko A, Schroeder-Kurth TM (1989) International Fanconi Anemia Registry: relation of clinical symptoms to diepoxybutane sensitivity. Blood 73:391-396
4. Butturini A, Gale RP, Verlander PC, Adler-Brecher B, Gillio AP, Auerbach AD (1994) Hematologic abnormalities in Fanconi: an International Fanconi Anemia registry study. Blood 84:1650-1655
5. Estey E, Kantarjian HM, O'Brien S, Kornblau S, Andreeff M, Beran M, Pierce S, Keating M (1995) High remission rate, short remission duration in patients with refractory anemia with excess of blasts (RAEB) in transformation (RAEB-t) given acute myelogenous leukemia (AML)-type chemotherapy in combination with granulocyte-CSF (G-CSF) Cytokines Mol Ther 1:21-28
6. Gluckmann E, Auerbach AD, Horowitz MM, Sobocinski KA, Ash RC, Bortin MM, Butturini A, Camitta BM, Champlin RE, Friedrich W (1995) Bone marrow transplantation for Fanconi anemia. Blood 86:2856-2862
7. Hiddemann W, Kreutzmann H, Straif K, Ludwig WD, Mertelsmann R, Donhuijsen Ant R, Lengfelder E, Arlin Z, Büchner T (1987) High-dose cytosine arabinoside and mitoxantrone: a highly effective regimen in refractory acute myeloid leukemia. Blood 69:744-749
8. Hiddemann W, Aul C, Maschmeyer G, Schönrock-Nabulsi R, Ludwig W, Bartholomäus A, Bettelheim P, Becker K, Balleisen L, Lathan B, Köppler H, Grüneisen T, Donhuijsen-Ant R, Reichte A, Heinecke A, Sauerland C, Büchner T (1993) High-dose versus intermediate-dose cytosine arabinoside combined with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia: results of an age-adjusted randomized comparison. Leukemia Lymphoma 10 [Suppl]:133-137
9. Joenje H, Lo-ten-Foe JR, Oostra AB, van Berkel CG, Rooimans MA, Schroeder-Kurth T, Wegner RD, Gille JJ, Buchwald M, Arwert F (1995) Classification of Fanconi anemia patients by complementation analysis: evidence for a fifth genetic subtype. Blood 86:2156-2160
10. Liu JM, Buchwald M, Walsh EC, Young NS (1994) Fanconi anemia and novel strategies for therapy. Blood 3995-4007
11. Preisler HD, Raza M, Barcos M (1986) High-dose cytosine arabinoside in the treatment of preleukemic disorders: an intergroup study. Am J Hematol 23:131-134
12. Schindler D, Kubbies M, Hoehn H, Schinzel A, Rabinovitch PS (1987) Confirmation of Fanconi anemia and detection of chromosomal aberration (1q12-32 triplication) via BrdU/ Hoechst flow cytometry. Am J Pediatr Hematol Oncol 9:172-177
13. Tricot G, Vlietinck R, Boogaerts MA, Hendrickx B, De Wolf-Peeters C, Van den Berghe H, Verwilghen RL (1985) Prognostic factors in myelodysplastic syndromes: importance of initial data on peripheral blood counts, bone marrow cytology, trephine biopsy and chromosomal analysis. Br J Haematol 60:19-32
14. Verbeek W, Wörmann B, Koch P, Aul C, Hinrichs H, Balleisen L, Bennett J, Büchner T, Hiddemann W (1997) S-HAM induction chemotherapy with or without GM-CSF in patients with high-risk myelodysplastic syndromes. Ann Hematol 74:205-208